Edit Content
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Rare Hemophilia Factors Market to reach USD 502.58 million by the end of 2030

Global Rare Hemophilia Factors Market Size Study & Forecast, by Type (Factor I, Factor II, Factor V, Factor VII, Factor X, Factor XI, Factor XIII), by Treatment (Factor Concentrates, Fresh Frozen Plasma, Cryoprecipitate, Others) and Regional Analysis, 2023-2030

Product Code: HLSMDE-45623804
Publish Date: 15-11-2023
Page: 200

Global Rare Hemophilia Factors Market is valued at approximately USD 294.7 million in 2022 and is anticipated to grow with a healthy growth rate of more than 6.9% over the forecast period 2023-2030. Hemophilia is a genetic disorder that affects blood clotting, caused by a deficiency in clotting factors such as Factor VII, Factor IX, and Factor XIII. The market for rare hemophilia factors is growing due to advancements in early and accurate diagnosis, which helps healthcare providers identify patients with specific types of hemophilia and determine the best treatment options. Healthcare professionals and patients are becoming more aware of these advancements, and new treatment techniques that are being developed.

Also, the rising adoption and approval of new treatment techniques are driving the market. As per the article published by the National Institute of Health in 2021 under the title ‘Recent Advances in the Treatment of Hemophilia: A Review’, with the introduction of a bi-specific monoclonal antibody, a new era of prevention and treatment of bleeding started that clones the effects of Factors VIII in the tenase complex. The ongoing research to improve the efficacy and safety of rare hemophilia factor products is creating an opportunity for the market. The use of digital health technologies such as telemedicine and mobile health apps can be used to improve patients’ self-management. However, the high cost of treatments remains a significant challenge, especially in low-income countries. Also, the reimbursement policies have a significant impact on access to treatment.

The key regions considered for the Global Rare Hemophilic Factors Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 due to the government’s initiatives to increase diagnosis rates and reduce treatment costs, research activities, and therapeutic advances in hemophilia. The National Organization for Rare Disorders (NORD) offers various research grants to study rare diseases. Furthermore, recent approvals by the U.S. FDA for some coagulation factor concentrates have assisted in boosting the regional market. Asia Pacific is expected to grow significantly over the forecast period, due to the rising incidence of autosomal recessive disorders in countries such as India, Pakistan, and China. According to a study titled “Epidemiological study of consanguineous marriage and its effects” published in the International Journal of Community Medicine and Public Health, the Middle East, Africa, and South Asia have a high prevalence of consanguineous marriages, estimated to be around 20.0% to 50.0% of all marriages.

Major market player included in this report are:
Novo Nordisk A/S
Biogen Inc.
Bayer Healthcare
Pfizer, Inc.
Shire Plc
Sanofi S.A
CSL Behring
Bio Products Laboratory Ltd.
Eli Lilly and Company
GSK Plc

Recent Developments in the Market:
Ø In February 2022, Biocon acquired Viatris’ biosimilar portfolio, which resulted in strengthening its product offerings and revenue generation.
Ø In May 2022, F. Hoffmann-La Roche Ltd., a Swedish multinational healthcare company, extended its partnership with the World Federation of Hemophilia (WFH) until 2028 to provide access to hemophilia treatments. The company offer its prophylactic treatment for hemophilia A to the WFH’s Humanitarian Aid Program, that distribute it to people in areas with limited access to quality hemophilia treatments.
Ø In May 2022, Takeda Pharmaceutical Co Ltd launched Adynovate, an innovative extended half-life recombinant Factor VIII treatment in India for hemophilia A patients.
Ø In June 2022, the United States Food and Drug Administration granted breakthrough therapy designation to ‘efanesoctocog alfa’ for hemophilia A. This therapy is the first factor VIII therapy to be awarded Breakthrough Therapy designation by the FDA, based on data from the XTEND-1 Phase 3 study, which demonstrated clinically meaningful prevention of bleeds and superiority in the prevention of bleeding episodes compared to prior prophylaxis factor treatment.
Ø In August 2022, The Food and Drug Administration (FDA) announced the approval of Rebinyn, a coagulation factor IX recombinant, received approval for routine prophylaxis to reduce the frequency of bleeding episodes in children and adults with hemophilia B.

Global Rare Hemophilic Factors Market Report Scope:
ü Historical Data – 2020 – 2021
ü Base Year for Estimation – 2022
ü Forecast period – 2023-2030
ü Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
ü Segments Covered – Type, Treatment, Region
ü Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa
ü Customization Scope – Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Type offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:
Factor I
Factor II
Factor V
Factor VII
Factor X
Factor XI
Factor XIII

By Treatment:
Factor Concentrates
Fresh Frozen Plasma
Cryoprecipitate
Others

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
1.2.1. Rare Hemophilia Factors Market, by Region, 2020-2030 (USD Million)
1.2.2. Rare Hemophilia Factors Market, by Type, 2020-2030 (USD Million)
1.2.3. Rare Hemophilia Factors Market, by Treatment, 2020-2030 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Rare Hemophilia Factors Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Rare Hemophilia Factors Market Dynamics
3.1. Rare Hemophilia Factors Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Growing adoption and approval of new treatment techniques
3.1.1.2. Increased awareness about rare hemophilia disease
3.1.2. Market Challenges
3.1.2.1. High Cost of Rare Hemophilia treatments
3.1.2.2. Inadequate reimbursement
3.1.3. Market Opportunities
3.1.3.1. Ongoing research & development
3.1.3.2. Use of digital health technologies
Chapter 4. Global Rare Hemophilia Factors Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Rare Hemophilia Factors Market, by Type
5.1. Market Snapshot
5.2. Global Rare Hemophilia Factors Market by Type, Performance – Potential Analysis
5.3. Global Rare Hemophilia Factors Market Estimates & Forecasts by Type 2020-2030 (USD Million)
5.4. Rare Hemophilia Factors Market, Sub-Segment Analysis
5.4.1. Factor I
5.4.2. Factor II
5.4.3. Factor V
5.4.4. Factor VII
5.4.5. Factor X
5.4.6. Factor XI
5.4.7. Factor XIII
Chapter 6. Global Rare Hemophilia Factors Market, by Treatment
6.1. Market Snapshot
6.2. Global Rare Hemophilia Factors Market by Treatment, Performance – Potential Analysis
6.3. Global Rare Hemophilia Factors Market Estimates & Forecasts by Treatment 2020-2030 (USD Million)
6.4. Rare Hemophilia Factors Market, Sub Segment Analysis
6.4.1. Factor Concentrates
6.4.2. Fresh Frozen Plasma
6.4.3. Cryoprecipitate
6.4.4. Others
Chapter 7. Global Rare Hemophilia Factors Market, Regional Analysis
7.1. Top Leading Countries
7.2. Top Emerging Countries
7.3. Rare Hemophilia Factors Market, Regional Market Snapshot
7.4. North America Rare Hemophilia Factors Market
7.4.1. U.S. Rare Hemophilia Factors Market
7.4.1.1. Type breakdown estimates & forecasts, 2020-2030
7.4.1.2. Treatment breakdown estimates & forecasts, 2020-2030
7.4.2. Canada Rare Hemophilia Factors Market
7.5. Europe Rare Hemophilia Factors Market Snapshot
7.5.1. U.K. Rare Hemophilia Factors Market
7.5.2. Germany Rare Hemophilia Factors Market
7.5.3. France Rare Hemophilia Factors Market
7.5.4. Spain Rare Hemophilia Factors Market
7.5.5. Italy Rare Hemophilia Factors Market
7.5.6. Rest of Europe Rare Hemophilia Factors Market
7.6. Asia-Pacific Rare Hemophilia Factors Market Snapshot
7.6.1. China Rare Hemophilia Factors Market
7.6.2. India Rare Hemophilia Factors Market
7.6.3. Japan Rare Hemophilia Factors Market
7.6.4. Australia Rare Hemophilia Factors Market
7.6.5. South Korea Rare Hemophilia Factors Market
7.6.6. Rest of Asia Pacific Rare Hemophilia Factors Market
7.7. Latin America Rare Hemophilia Factors Market Snapshot
7.7.1. Brazil Rare Hemophilia Factors Market
7.7.2. Mexico Rare Hemophilia Factors Market
7.8. Middle East & Africa Rare Hemophilia Factors Market
7.8.1. Saudi Arabia Rare Hemophilia Factors Market
7.8.2. South Africa Rare Hemophilia Factors Market
7.8.3. Rest of Middle East & Africa Rare Hemophilia Factors Market

Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.1.1. Company 1
8.1.2. Company 2
8.1.3. Company 3
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Novo Nordisk A/S
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Recent Developments
8.3.2. Biogen Inc.
8.3.3. Bayer Healthcare
8.3.4. Pfizer, Inc.
8.3.5. Shire Plc
8.3.6. Sanofi S.A
8.3.7. CSL Behring
8.3.8. Bio Products Laboratory Ltd.
8.3.9. Eli Lilly and Company
8.3.10. GSK Plc
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now